Korro Bio, Inc. - KRRO Net Assets per Single Share

Graphic logo of Korro Bio (KRRO)

The Korro Bio, Inc. (KRRO) price chart reflects the quotes of a company facing stringent FDA oversight and massive patenting costs for its OPERA system. The indicator stands at 6.98, while business success relies on primary test results and support from pharma behemoths to reduce cash burn. Consequently, Korro Bio, Inc. (KRRO) is creating a cutting-edge environment for correcting genetic malfunctions in the lungs and liver without DNA editing.

Korro Bio, Inc. (KRRO) Equity per Share: for the period 02/21/2024 - 10/27/2026

Korro Bio Inc. - analytical breakdowns and key metrics (KRRO)

- price and consensus price forecast:
Price Chart Korro Bio, Inc|KRRO - Fair Value Consensus
- market capitalization data:
Market Value Korro Bio, Inc.|KRRO - Total Enterprise Value
- book capitalization data:
Book Value per Share Korro Bio|KRRO - Accounting Capitalization|Market Value to Book Value Ratio korrobio.com|KRRO - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Korro Bio, Inc.|KRRO - Long-Term Debt to Capital|Short-Term Debt to Equity Korro Bio, Inc|KRRO - Company Aggregate Debts|Debt to Book Capitalization Ratio Korro Bio, Inc.
Fundamental company valuation:korrobio.com, KRRO
Manufactured products of Korro Bio, Inc

Book value reflects the difference between all assets and liabilities of Korro Bio, Inc. (KRRO), determining the intrinsic value per share to assess real capital. The trend in net assets per share confirms the effectiveness of investments in cold chain logistics and the global RNA drug supplier network, allowing investors to judge the preservation of funds amidst the high technological complexity of the business.

Competitor analysis for Korro Bio, Inc.

Net Assets per Single Share Tempus AI, Inc. (TEM)|QGEN: Accounting Value of a Share|Net Assets per Single Share IONS|repligen.com (RGEN) - Net Asset Value per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|sarepta.com - Book Value per Share|Twist Bioscience, Inc. - Net Assets per Single Share|TXG: Book Value per Share|Net Assets per Single Share NTLA|STOK (Stoke Corp) - Net Asset Value per Share|BLFS - Net Assets per Single Share|Accounting Value of a Share WVE|Maze Therapeutics (MAZE) - Net Assets per Single Share|Accounting Value of a Share SION (Sionna Therapeutics, Inc.)|PRME: Net Assets per Single Share|TSHA - Net Asset Value per Share|Accounting Value per Share uniQure N.V. (QURE)|MGTX - Accounting Value of a Share|REGENXBIO (RGNX) - Book Value per Share|Solid Biosciences Inc (SLDB) - Net Assets per Single Share|OCGN: Book Value per Share|Net Assets per Share PACB|Benitec Biopharma Inc. - Net Assets per Single Share|Net Asset Value per Share designtx.com DSGN|Accounting Value per Share Rocket Pharmaceuticals, Inc.|Accounting Value of a Share 4DMT FDMT|Book Value per Share LXEO (Lexeo)|EDIT: Net Assets per Share|Net Assets per Single Share Silence Therapeutics|ProQR Therapeutics (PRQR) - Equity per Share|Book Value per Share CDXS|Accounting Value per Share Sangamo Therapeutics Inc. (SGMO)|NAUT (Nautilus Biotechnology) - Accounting Value per Share|Net Assets per Share MGX (Metagenomi Therapeutics)|Net Assets per Single Share DTIL (Precision BioSciences, Inc.)|Generation Bio Co - Book Value per Share|Net Assets per Single Share Boundless Bio (BOLD)|XCUR: Accounting Value of a Share|Net Assets per Single Share imunon.com IMNN|PHIO (Phio Pharmaceuticals Corp.) - Accounting Value of a Share|Net Assets per Single Share MBIO (Mustang Bio Inc)|Net Asset Value per Share TransCode|Book Value per Share Bionano Genomics, Inc. BNGO|Equity per Share APDN (Applied DNA Sciences Inc)|BLUE - Net Assets per Single Share|Equity per Share ImmunoPrecise Antibodies Ltd IPA|Omega Therapeutics - Book Value per Share|OMIC: Book Value per Share|RGLS: Net Assets per Single Share|SYRS (Syros Pharmaceuticals Inc.) - Book Value per Share|Net Assets per Single Share TBIO (Codex DNA)|Net Asset Value per Share TCON|Unity Biotechnology (UBX) - Net Assets per Single Share